CD4 and myeloid sarcoma: Figure 1a shows the differences in CD4+ T-lymphocyte activation between patients with MS (MS multiple sclerosis) and healthy control subjects (HC healthy controls); the numbers of activated CD4+ T-lymphocytes in samples incubated with and without the different MBPs (Δq4) are shown.